Solasta Ventures
Venture capitalBoston Β· Series AβSeries C Β· 6 people tracked
Investment thesis
Solasta Ventures focuses on translating scientific innovations into patient-centric healthcare solutions. The firm prioritizes therapeutics and medical technologies that transform patient care in U.S. and global markets, supported by experienced management teams capable of strategic capital allocation. The firm seeks to create value through potential collaborations with global pharmaceutical companies, particularly those in its South Korean network, positioning itself as a bridge between U.S. and Korean life sciences ecosystems.
Source: firm website, verified Jul 21, 2026.
Team Β· 6 people
from the firm's websiteWhat they invest in
from 10 of 30 portfolio companiesBiotech Γ9Medical Devices Γ4Deep Tech Γ3Healthtech Γ2AI & Machine Learning Γ1B2B Marketplaces Γ1Digital Health Γ1E-commerce Γ1
HQs:United StatesΓ4
Investments Β· 30 tracked
founders shown can be your intro pathArvinas is a clinical-stage biopharmaceutical company developing PROTAC protein degrader therapies for oncology and neurology. The company focuses on discovering and developing novel investigational drugs for patients with limited or ineffective treatment options.
Biotech
Axonis Therapeutics develops medicines targeting KCC2 to restore inhibition in the brain, with a focus on treating neurological disorders including epilepsy and pain. The company translates discoveries from Boston Children's Hospital, Harvard, and Laval University into first-in-class and best-in-class treatments.
BiotechMedical DevicesBoston, US
Boxhub operates an online marketplace for buying and selling shipping containers, modernizing the traditionally fragmented container trade through digital technology. The platform serves entrepreneurs, businesses, and individuals seeking to purchase containers for shipping, storage, living spaces, and alternative structural applications.
B2B MarketplacesE-commerceLogistics & Supply Chain
Maxmillian Birner(Co-Founder & CEO)
G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.
Biotech
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies. The company is building on research from academic institutions including Dana Farber Cancer Institute and MIT.
BiotechDigital HealthMedical Devices
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.
BiotechDeep TechHealthtech
BiotechAustin, US
Orions Bio discovers, designs and engineers molecules that connect proteins on and within cells to reprogram disease-driving processes or activate immune responses. The company develops small molecule drugs, conditionally active cytokines, and multimodal cell engagers for cancer, autoimmune diseases, and neurodegenerative disorders.
BiotechDeep TechHealthtech
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases. The company applies synthetic biology approaches to design programmable therapeutic candidates for patients.
BiotechDeep TechMedical Devices
ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs. The company is focused on rare genetic conditions including cystic fibrosis and primary ciliary dyskinesia.
AI & Machine LearningBiotechMedical Devices
Dr. Daniel J. Siegwart
Frequently asked questions
- What stage does Solasta Ventures invest at?
- Solasta Ventures invests at the Series A, Series B, Series C stages.
- What sectors does Solasta Ventures focus on?
- Solasta Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Solasta Ventures located?
- Solasta Ventures is headquartered in Boston, KR.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.